Pharmaceutical News and Articles

FDA Approves New Drug to Treat Alzheimer's, Kisunla

A new drug to treat Alzheimer s disease was approved by the U.S. Food and Drug Administration on Tuesday. In clinical trials, donanemab (Kisunla) modestly slowe

Allergy-Related Psychological Distress Common

Psychological distress related to food allergies (FA) is common globally, according to a study published online June 21 in Allergy.Rebecca C. Knibb, Ph.D., from

U.S. Government to Pay Moderna $176 Million to Develop mRNA Flu Vaccine

U.S. health officials announced Tuesday that the federal government will pay Moderna 176 million to speed development of a pandemic flu vaccine based on mRNA te

FDA Approves Kisunla (donanemab-azbt) for the Treatment of Early Symptomatic Alzheimer's Disease

FDA Approves New Drug to Treat Alzheimer's

A new drug to treat Alzheimer s disease was approved by the U.S. Food and Drug Administration on Tuesday.In clinical trials, donanemab (Kisunla) modestly slowed

Ultrasound May Be Unreliable in Spotting Endometrial Cancer in Black Women

Ultrasound cannot reliably rule out endometrial cancer in Black women given how readings are now assessed, a new study argues. Transvaginal ultrasound is common

Some Genes Might Send Girls Into Puberty Earlier

A girl s genetics can indirectly influence the age when she has her first period, by accelerating her weight gain in childhood, a new study finds. A number of o

Transgender, Gender-Diverse Adults Face Higher Risk for Experiencing Violence

Transgender and gender-diverse individuals have a higher risk for experiencing all forms of violence compared with cisgender women, according to a study publish

Supreme Court to Hear Case Challenging FDA's Ban of Flavored Vapes

In a case that will test the U.S. Food and Drug Administration s authority to approve or reject new vaping products, the U.S. Supreme Court said Tuesday it will

Perioperative Chemo Improves Progression-Free Survival in Pancreatic Cancer

For patients with resectable pancreatic ductal adenocarcinoma (PDAC), the 12-month progression-free survival (PFS) may be increased with neoadjuvant modified 5-